Skip to content

Provider profile

MMS Holdings.

Clinical biometrics

MMS Holdings (MMS) describes itself as a data-focused CRO. It documents biostatistics and analysis plans, statistical programming in SAS with CDISC SDTM/ADaM datasets and ISS/ISE, DSMB support, data management and EDC builds, and real-world evidence analytics for Phase I–IV studies, as full-service biometrics or FSP. It lists offices in Canton, Michigan, Bangalore and Hyderabad, India, and Belfast, UK.

Website
mmsholdings.com (opens in a new tab)
Sources reviewed
November 3, 2026 · Source pages re-checked within 4 months
First published
November 3, 2026

This profile summarizes what public sources state about the provider, mostly its own website. It is not an audit, qualification or endorsement by ArgusBio. Confirm capabilities directly with the provider before contracting.

Services and capabilities

Services and capabilities

  • Adaptive and Bayesian design6
  • Biostatistics1,2
  • CDISC data standards1,5
  • Clinical data management4
  • Data monitoring committee support5
  • EDC and database build4
  • Integrated analyses (ISS/ISE)5
  • Real-world evidence analytics1
  • Statistical analysis plans1,2
  • Statistical programming1,3
  • Submission data packages1,5

Platforms and methods

Engagement model

  • Full-service1Stated as full-service biometrics
  • Functional service provision (FSP)3

Development experience

Development experience

Development stage

  • Commercial5Stated as Phase IV programming support
  • Phase 15Stated for statistical programming support (Phase I–IV)
  • Phase 25Stated for statistical programming support (Phase I–IV)
  • Phase 35Stated for statistical programming support (Phase I–IV)

Therapeutic experience

  • Neuroscience / CNS7
  • Oncology7
  • Rare diseases7

Locations

Locations

  • Bangalore, India · Office8
  • Hyderabad, India · Office8
  • Belfast, United Kingdom · Office8Listed by the company as its Europe office
  • Canton, United States · Office8Listed by the company as its North America address

Quality and regulatory

Quality and regulatory

No quality framework or accreditation is established from reviewed sources. Ask for current certificates and recent inspection history.

Unknowns and questions to ask

Unknowns and questions to ask

Public sources rarely establish what matters most for a specific project. Confirm directly:

  • Named statistician and programming lead for your study, and their recent experience in your indication
  • Current capacity and realistic start date for database build and SAP authoring
  • Which CDISC standard versions and FDA Data Standards Catalog requirements they will deliver against
  • EDC system(s) supported and who holds the licence
  • Assumptions behind the budget: number of TLFs, interim analyses, DMC meetings and data transfers
  • How change orders are triggered and priced

Not established from reviewed sources: quality frameworks (vendor-reported).

How to choose a clinical biometrics CRO for a Phase 2 trial

Evidence and sources

Evidence and sources

  1. 1Biometric Solutions & Clinical Research Data Management (opens in a new tab)MMS Holdings · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  2. 2Biostatistics services | Biostatistics consulting (opens in a new tab)MMS Holdings · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  3. 3Functional Service Provider (FSP) Model Solutions (opens in a new tab)MMS Holdings · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  4. 4Clinical Data Management Services | Global Experts (opens in a new tab)MMS Holdings · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  5. 5Statistical Programming CRO Services (opens in a new tab)MMS Holdings · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  6. 6Clinical Statistical Consulting Services (opens in a new tab)MMS Holdings · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  7. 7Therapeutic Expertise in Oncology, Rare Disease & Psychedelics (opens in a new tab)MMS Holdings · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  8. 8Contact US | MMS Holdings (opens in a new tab)MMS Holdings · Provider website · retrieved November 3, 2026 · last checked November 3, 2026

“Last checked” means we confirmed the page was still available and still contained the cited statement. It does not mean ArgusBio verified the provider or its capabilities.

Something out of date or wrong? Request a correction. Corrections are reviewed against public sources before publication.

Contact

Contact

Contact the provider directly through its public contact page (opens in a new tab). ArgusBio does not forward inquiries to providers and does not receive referral fees.

Compare with other clinical biometrics providers

ArgusBio sourcing

Need help evaluating this provider or comparing alternatives.

Discuss your sourcing need with ArgusBio. We can help define the scope, identify comparable alternatives and organize proposals so the decision stays yours.

Discuss a sourcing need

We work for the biotech, not the vendor. Vendors do not pay for inclusion or placement.